[Elsevier] LANCET - Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial |
|
This post will be closed automatically in 2026-08-21 01:01
Best Answer
1 hour(s) ago
|
| |
post
reply
points
2565
50
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study
10
On the Suitability of Porcine Labial Mucosa as a Model for Buccal Mucosal Drug Delivery Research
10
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
10
Waste clay brick powder as a sustainable precursor for structural geopolymer concrete: Mechanical, durability and microstructural characteristics
10
Sunlight mediated enhanced photocatalytic degradation of antibiotics in aqueous medium using silicon doped carbon quantum dots decorated Bi2MoO6 nanoflakes
